Triggers when the user asks to analyze a deal, assess deal health, score a deal, validate a deal stage, identify deal risks, or evaluate pipeline quality. Also triggers on phrases like "how healthy is this deal", "what's the risk on [company]", "is this deal real", "should we forecast this", or "MEDDIC score".
From sales-enablementnpx claudepluginhub cjf-iii/sales-enablement-pluginThis skill is limited to using the following tools:
Guides Next.js Cache Components and Partial Prerendering (PPR) with cacheComponents enabled. Implements 'use cache', cacheLife(), cacheTag(), revalidateTag(), static/dynamic optimization, and cache debugging.
Migrates code, prompts, and API calls from Claude Sonnet 4.0/4.5 or Opus 4.1 to Opus 4.5, updating model strings on Anthropic, AWS, GCP, Azure platforms.
Details PluginEval's skill quality evaluation: 3 layers (static, LLM judge), 10 dimensions, rubrics, formulas, anti-patterns, badges. Use to interpret scores, improve triggering, calibrate thresholds.
Activate this skill when:
data/memory/deals/ for an existing deal file matching the company namedata/memory/companies/ for the company profiledata/memory/contacts/ for all contacts associated with this dealdata/memory/learnings/stage-progression.md for historical patternsScore each dimension on a 1-10 scale using the rubric below. Be honest — inflated scores help nobody.
Cross-reference the claimed stage against the stage-gate criteria. Deals frequently sit at a stage they haven't truly earned. Call it out.
Apply the weighted risk model. Identify the top 3 risk factors and their mitigation paths.
Output the structured Deal Health Card (template below) with scoring, risk assessment, and concrete next actions.
data/memory/deals/data/memory/learnings/stage-progression.md if this analysis reveals a patternMEDDIC is the gold standard for enterprise deal qualification. Each letter represents a dimension that must be validated — not assumed, not hoped for, validated with evidence.
What it means: The quantified business impact the buyer expects from your solution. Not "they want better performance" — actual numbers tied to their P&L.
| Score | Criteria |
|---|---|
| 1-2 | No metrics identified. Conversation is feature-focused, not outcome-focused. |
| 3-4 | Vague metrics: "improve efficiency" or "grow revenue." No baseline, no target. |
| 5-6 | General metrics identified but not validated by the buyer. You've done the math, they haven't confirmed it. |
| 7-8 | Buyer has confirmed specific metrics: "We need to reduce CPA by 20%" or "grow audience reach by 3M impressions." Baseline and target are documented. |
| 9-10 | Metrics are buyer-authored, tied to a business case or internal initiative, and have been presented to their leadership. The buyer is using YOUR metrics in THEIR internal conversations. |
Red flags at low scores:
How to improve:
What it means: You have identified AND engaged the person who can sign the contract and allocate budget without further approval. This is the single most important dimension.
| Score | Criteria |
|---|---|
| 1-2 | Unknown. You're talking to someone who "thinks" they can make the decision. |
| 3-4 | Identified by name/title but no direct engagement. Your champion says they'll "handle it internally." |
| 5-6 | Identified and you've had one interaction (email, brief meeting), but no substantive conversation about the deal. |
| 7-8 | Direct engagement. Economic buyer understands the value proposition, has confirmed budget availability, and has expressed a timeline preference. |
| 9-10 | Economic buyer is actively driving the deal internally. They've asked their team to prioritize evaluation, allocated resources for implementation, or issued verbal commitment. |
Red flags at low scores:
How to improve:
What it means: You know the specific criteria the buyer will use to evaluate solutions AND you've influenced those criteria in your favor.
| Score | Criteria |
|---|---|
| 1-2 | No understanding of how they'll decide. You're guessing. |
| 3-4 | General sense: "they care about price and integration." No formal criteria documented. |
| 5-6 | Buyer has shared their evaluation criteria (maybe an RFP or scorecard), but you haven't influenced it. |
| 7-8 | Criteria are documented, and at least 2-3 criteria favor your solution because you helped shape them. |
| 9-10 | You co-authored the evaluation criteria. The scorecard reads like your feature sheet. Competitor would need to rewrite the RFP to win. |
Red flags at low scores:
What it means: You understand every step between today and a signed contract — and you've validated it with the buyer, not inferred it from past deals.
| Score | Criteria |
|---|---|
| 1-2 | No idea. "They said they'd get back to us." |
| 3-4 | General sense: "They need legal review and board approval." No timeline, no sequence. |
| 5-6 | Process steps identified (eval → pilot → legal → sign), but no dates committed and no mutual action plan. |
| 7-8 | Mutual action plan exists with dates. Both sides have committed resources. You know the approval chain. |
| 9-10 | Joint execution plan with milestones, calendar holds for key meetings, legal/procurement pre-engaged, and a fallback timeline if things slip. |
Red flags at low scores:
What it means: You understand the specific business pain this deal solves — not the feature they want, but the PROBLEM that's costing them money, time, or competitive position.
| Score | Criteria |
|---|---|
| 1-2 | No pain identified. Buyer is "exploring options" or "seeing what's out there." |
| 3-4 | Surface-level pain: "We need a better ad platform" or "Our current vendor is too expensive." |
| 5-6 | Real pain identified and articulated: "We're losing 30% of our digital budget to fraud" or "Our campaign setup takes 3 weeks instead of 3 days." |
| 7-8 | Pain is quantified, attributed to a business impact (revenue loss, margin compression, competitive disadvantage), and acknowledged by multiple stakeholders. |
| 9-10 | Pain is urgent. There's a compelling event — a contract expiration, a board mandate, a regulatory deadline, a competitive threat — that creates a "must solve by X date" dynamic. |
Red flags at low scores:
How to improve:
What it means: You have an internal advocate who has POWER (not just interest), INFLUENCE (people listen to them), and MOTIVATION (they personally benefit from your solution winning).
| Score | Criteria |
|---|---|
| 1-2 | No internal advocate. You're selling from the outside. |
| 3-4 | Friendly contact who takes your calls, but has no influence on the decision. |
| 5-6 | Advocate with some influence who is willing to share information and make introductions. |
| 7-8 | Champion who actively sells internally on your behalf, coaches you on objections and politics, and has credibility with the economic buyer. |
| 9-10 | Champion who has staked their reputation on this deal. They're presenting to their leadership, removing internal blockers, and proactively sharing competitive intelligence. |
Red flags at low scores:
Deals frequently sit at stages they haven't earned. Use these gates to validate.
data/memory/wins/Each risk factor has a weight. Total risk score = sum of (factor score x weight). Higher = more risk.
| Risk Factor | Weight | Score Range | How to Assess |
|---|---|---|---|
| No economic buyer access | 0.25 | 0-10 | 0 = direct access, 10 = never met them |
| Single-threaded (one contact) | 0.15 | 0-10 | 0 = 5+ contacts, 10 = only 1 contact |
| No compelling event | 0.20 | 0-10 | 0 = hard deadline, 10 = "whenever" |
| Champion weakness | 0.15 | 0-10 | 0 = strong champion, 10 = no champion |
| Competitive threat | 0.10 | 0-10 | 0 = no competition, 10 = incumbent advantage |
| Stalled progression | 0.10 | 0-10 | 0 = moving fast, 10 = no activity 30+ days |
| Budget uncertainty | 0.05 | 0-10 | 0 = budget allocated, 10 = no budget discussion |
Risk Categories:
Based on the MEDDIC scores and risk factors, recommend actions from this library:
# Deal Health Card: [Company Name]
**Generated:** [Date]
**Deal Value:** $[value]
**Current Stage:** [stage] (Validated: [Yes/No])
**Close Date:** [target date]
**Days in Current Stage:** [N]
## MEDDIC Scorecard
| Dimension | Score | Evidence | Gap |
|---|---|---|---|
| Metrics | [1-10] | [Brief evidence] | [What's missing] |
| Economic Buyer | [1-10] | [Brief evidence] | [What's missing] |
| Decision Criteria | [1-10] | [Brief evidence] | [What's missing] |
| Decision Process | [1-10] | [Brief evidence] | [What's missing] |
| Identify Pain | [1-10] | [Brief evidence] | [What's missing] |
| Champion | [1-10] | [Brief evidence] | [What's missing] |
| **TOTAL** | **[X/60]** | | |
## Stage Validation
Current Stage: [N] — [Name]
Gate Status: [PASSED / FAILED — list failing criteria]
Recommended Stage: [N] — [Name]
## Risk Assessment
Overall Risk Score: [X.X / 10.0] — [Low/Moderate/High/Critical]
Top 3 Risk Factors:
1. [Factor]: [Score] — [Why]
2. [Factor]: [Score] — [Why]
3. [Factor]: [Score] — [Why]
## Recommended Next Actions (Priority Order)
1. **[Action]** — [Rationale] — Owner: [who] — By: [date]
2. **[Action]** — [Rationale] — Owner: [who] — By: [date]
3. **[Action]** — [Rationale] — Owner: [who] — By: [date]
## Deal Narrative
[2-3 sentence honest assessment of where this deal stands, what needs to happen
for it to close, and what the biggest single risk is. Written for a VP of Sales
who needs the truth, not optimism.]
After each deal analysis:
data/memory/learnings/stage-progression.md[Date] [Company] claimed Stage [N] but validated at Stage [N-1]. Gap: [dimension][Date] [Company] risk flag [factor] confirmed. Outcome: [what happened]data/memory/learnings/win-rate-factors.md and update if the analysis reveals a patternHere is what an excellent Deal Health Card looks like in practice:
# Deal Health Card: Meridian Media Group
**Generated:** 2026-03-19
**Deal Value:** $480,000
**Current Stage:** 4 - Proposal (Validated: No — should be Stage 3)
**Close Date:** 2026-05-15
**Days in Current Stage:** 22
## MEDDIC Scorecard
| Dimension | Score | Evidence | Gap |
|---|---|---|---|
| Metrics | 7 | "Reduce CPA from $42 to $28 across programmatic" — confirmed by VP Marketing | Need CFO validation of savings model |
| Economic Buyer | 4 | CMO identified (Sarah Chen), one email exchange only | No direct meeting. Champion says "she'll approve" but no evidence. |
| Decision Criteria | 5 | Shared evaluation scorecard, but written by procurement — not shaped by us | Need to influence technical criteria around real-time optimization |
| Decision Process | 3 | "Legal will review after we decide" — no timeline, no mutual plan | No action plan. No clarity on procurement timeline. |
| Identify Pain | 8 | CPA inflation + audience fragmentation costing $1.2M/yr in wasted spend. CFO flagged in board meeting. | Pain is strong but need to confirm it's a THIS QUARTER priority |
| Champion | 6 | Director of Digital (Marcus Lee) is engaged and making intros, but hasn't presented to CMO yet | Not yet selling internally without us in the room |
| **TOTAL** | **33/60** | | |
## Stage Validation
Current Stage: 4 — Proposal
Gate Status: FAILED — Economic Buyer < 6, Decision Process < 6, no mutual action plan
Recommended Stage: 3 — Qualification
## Risk Assessment
Overall Risk Score: 5.8 / 10.0 — High Risk
Top 3 Risk Factors:
1. No economic buyer access: 7.5 — One email is not access. CMO has not engaged.
2. No compelling event: 6.0 — Pain is real but no deadline forcing action.
3. Single-threaded risk: 5.0 — Only Marcus is engaged. If he leaves or deprioritizes, deal dies.
## Recommended Next Actions (Priority Order)
1. **Get CMO meeting** — Ask Marcus to set up a 20-min exec alignment call. Offer to bring your VP. — Owner: AE — By: This week
2. **Build mutual action plan** — Draft a reverse-timeline from May 15 close date. Share with Marcus for validation. — Owner: AE — By: 3 days
3. **Multi-thread** — Request intro to the Programmatic team lead and the CFO's office (for budget validation). — Owner: AE — By: Next week
## Deal Narrative
This deal has real pain and decent metrics, but it's running on hope rather than process.
The biggest risk is that we've never spoken to the CMO directly, and we're 22 days into
"Proposal stage" without a mutual action plan. If we can't get CMO access in the next
10 days, this deal should be moved to Stage 3 and the close date pushed to Q3.